News – Abilita Therapeutics
Mar 23, 2022 · Abilita Bio, Inc. announced today a second research collaboration agreement with a major pharmaceutical partner, which will leverage Abilita Bio’s proprietary EMP™ membrane protein evolution platform to accelerate G protein-coupled receptor (GPCR) drug …
Abilita Therapeutics and Orion Announce Research Collaboration …
6 days ago · SAN DIEGO, Dec. 18, 2024 /PRNewswire/ -- Abilita Therapeutics, Inc. ("Abilita") today announced a global licensing and multi-target research collaboration with Finnish Orion Corporation...
Abilita Therapeutics and Orion Announce Research Collaboration …
6 days ago · Abilita Therapeutics, Inc. ("Abilita") today announced a global licensing and multi-target research collaboration with Finnish Orion Corporation ("Orion") focused on the discovery, development...
Abilita Therapeutics and Orion Announce Research ... - BioSpace
6 days ago · “This collaboration combines Abilita’s strength in discovering breakthrough antibody therapeutics for challenging membrane protein targets with Orion’s proven expertise in oncology, pain, clinical development, and commercialization,” said Mauro Mileni, Ph.D., founder and CEO of Abilita.“We are excited to leverage our EMP™ platform, the …
Orion and Abilita Therapeutics announce research collaboration …
Dec 18, 2024 · Orion Corporation (“Orion”) and Abilita Therapeutics (“Abilita”) announced today that they have entered into a research collaboration and option to license agreement to develop innovative antibody therapeutics in the areas of oncology and pain.
Abilita Therapeutics – LEADER IN DISCOVERING AND …
Dec 18, 2024 · news, events and other information from abilita therapeutics December 18, 2024 Abilita Therapeutics and Orion Announce Research Collaboration to Develop Next-Generation Antibody Therapeutics in the Areas of Oncology and Pain
Orion and Abilita Therapeutics announce research - GlobeNewswire
6 days ago · Orion Corporation (“Orion”) and Abilita Therapeutics (“Abilita”) announced today that they have entered into a research collaboration and option to license agreement to develop innovative...
Orion and Abilita Therapeutics announce research collaboration …
6 days ago · Orion Corporation (“Orion”) and Abilita Therapeutics (“Abilita”) announced today that they have entered into a research collaboration and option to license agreement to develop innovative...
Abilita Therapeutics and Orion Announce Research ... - Medindia
5 days ago · SAN DIEGO, Dec. 18, 2024 /PRNewswire/ -- Abilita Therapeutics, Inc. ("Abilita") today announced a global licensing and multi-target research collaboration with Finnish Orion Corporation ("Orion ...
Abilita Bio Changes Name to Abilita Therapeutics and Appoints …
Jun 1, 2023 · Abilita Therapeutics strengthens leadership team by appointing Joel Edwards as chief business officer to advance corporate strategy and partnering efforts.